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Start-up companies represent a powerful engine of the innovation process. The current study aims to establish a better 
understanding of the Start-up ecosystem in providing innovative healthcare solutions through the lens of intellectual 
property and relate it to policy gaps for supporting the Start-up ecosystem in India. This study found that about 
397 healthcare Start-up companies have been established after 1 January 2010. The Questel Orbit database was used to 
conduct a patent search for the patents filed by these Start-ups from 1 January 2010 to 1 May 2020. A total of 3527 patents 
were retrieved and analyzed thoroughly to generate insights on the year-wise patent filing trend, geographical patent filing 
density, top aggressive patent filers, sector-wise filing density and a glimpse ofthe patent filing culture of healthcare Start-
ups in India. The result shows that major filing has been done in the field of pharmaceuticals and biotechnology; and major 
healthcare market is the USA. Despite the Start-up culture being relatively new in India, the country’s healthcare Start-ups 
are among the top 10 patent filers globally. It is observed that Verily Life Sciences is the top healthcare patent filer globally 
and SigTuple is the top patent filer from India. 
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A Start-up is a young company involved in developing 
innovative product or services. In India, an entity is 
called a Start-up if it is incorporated within a period 
of last ten years as a private limited company or a 
partnership firm or a limited liability partnership. 
In addition, it should work towards innovation, 
development or improvement of products or processes 
or services; and the turnover of the entity in any 
financial year should not exceeded one hundred crore 
rupees.1 Start-ups are engines of growth—they disrupt 
the economy of a country and forces it to evolve 
through innovations.2 
According to a study conducted by University of 
California, the top five most popular Start-up sectors 
are Business-to-Business (B2B) Software and 
services, Healthcare, Consumer goods and services, 
Financial technology and Consumer Media.3 Start-up 
ecosystems are capable of innovating and creating 
jobs. Nasscom reported that India continues to the 
third largest start-up ecosystem after China and US.4 
The Indian Start-up ecosystem is rapidly expanding, 
and the country's entrepreneurial spirit is gaining 
momentum. Increased government backing, as well 
as increased investor confidence and technology 
breakthroughs, are transforming India's Start-up scene.5 
With government support, Indian Start-ups will 
undoubtedly have a huge impact on the country's 
transformation and economic progress as the country 
heals itself after the COVID 19 pandemic.6 
Intellectual property is considered an important 
priority for any Start-up that wants to cement its success. 
In short, the certain way for a Start-up to succeed against 
rivals is by patenting its inventions and innovations.7 
When a Start-up patents its ideas, its valuation increases. 
A quality patent portfolio can attract large MNCs that 
can further provide financial assistance to R&D or can 
acquire the company leading to a large payday for the 
founders. Patents are also considered as an asset and can 
be used as leverage to obtain monetary assistance from 
financial institutions.8 
The current study focuses on healthcare Start-ups. 
As Covid-19 keeps on devastating the world, it is 
even more important today to have a quality 
healthcare system in place. The current crisis has 
exposed the lack of medical infrastructure in India. 
According to WHO, the ratio of doctors to a number 
of patients should be 1:1000. However, in India, this 
ratio is 1:1445.9 The aim of the study is to understand 
the global patent landscape, i.e., the patenting 
scenario in the healthcare Start-up. Patent landscape 
reports provide a snapshot of the patent situation 
of a specific technology. They can help in policy 
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discussions, strategic research planning and technology 
transfer. The study first focuses on the global 
healthcare Start-up and their patent filing trends. Then 
it zooms into the scenario in India. Apart from the 
patenting trend in India, the study also deals with the 
Start-up ecosystem status in India, various Government 
initiatives, and the future of healthcare sector in India. 
There is no globally accepted definition for a Start-
up. In India, A Start-up is defined as an entity that is 
headquartered in India and opened less than 10 years 
ago. Therefore, a comprehensive search was carried 
out by populating a list of all the companies which 
were labeled as a Start-up in various forums. Initially, 
a sample list of 882 healthcare Start-ups was 
compiled. However, several of them were more than 
10 years old but still being labeled as a Start-up. 
Hence, we selected the companies established in 
between 1st January 2010 to 1st May 2020. The final 
list contained 397 Start-ups. Next, the Questel Orbit 
database was used to find patent filed or owned by 
these Start-ups.10 This resulted in 3527 patent families. 
Bibliographic Data Analysis 
Priority country is the country where the first filing 
of a patent family occurs. This gives a general idea 
about the jurisdiction where maximum R&D is taking 
place. Result shows that the USA has the maximum 
number of patent filings (2679) followed by United 
Kingdom (415), European patent office (253), China 
(125), Australia (77), and India (65). Countries like 
South Korea (47), Japan (24), and Germany (68) also 
saw patent filings in the field of healthcare. 
Figure 1 shows the markets where the inventor/ 
assignee was interested in protecting their invention. It 
can be observed that the USA again leads with 1933 
patents being filed. It has also surpassed the European 
Patent Office (1845) filing which is noteworthy; 
considering EP provides the option to file in multiple 
countries at one go. Canada (675) which was not present 
in the top 10 patent filings based on priority country has 
outnumbered Japan (661), Australia (608), South Korea 
(403), and India (394). United Kingdom (327) which 
was second based on priority year comes last. 
Figure 2 depicts the priority year of the patent 
applications. An exponential increase can be seen till 
2017. Th e decrease in 2019-20 can be attributed to 
the lack of data as the patent applications might not 
have been published yet. 
Based on the technology domain, the patents have 
been classified into ten broad categories. Table 1 
shows the total number of patents in the respective 
categories. 
Verily Life Sciences emerged as the top patent filer 
with a total of 565 patent filings followed by ADC 
Therapeutics with 98 patent filings. It is evident from 
Table 2 that Verily Life Sciences have dominated most 
of the sectors in patent filings. This can be attributed to 
the fact that it is a subsidiary of Alphabet Inc, owner of 
Google. This provides the company access to much 
more capital for R&D expenditure and despite having 
founded only in 2015 it has raced far ahead of its peers. 
It is to be noted that the terms ‘Medical technology’ and 
‘Healthcare’ are often used interchangeably. However, 
‘Medical technology’ specifically refers to medical 
devices for treatment, monitoring, or diagnostic 
purposes whereas ‘Healthcare’ is a general term that 
Fig.1 — Global distribution of patent filings in healthcare sector 
Fig. 2 —Number of patents filings corresponding topriority year 
Table 1 — No. of patents filed by different healthcare 
Start-up sectors 
Healthcare sector Number of patents filed 
Pharmaceuticals 1255 
Medical technology 1148 
Biotechnology 693 
Computer technology 494 
Measurement 244 
Analysis of biological materials 234 
Optics 186 
Organic fine chemistry 161 
Telecommunications 93 
Control 75 
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encompasses medical technology along with 
prevention of lifestyle diseases, post-injury/ surgery 
care, etc. It can be seen that several patents have been 
filed in the field of telecommunications. This is done 
by assignees like RAPIDSOS, Verily Life Sciences, 
Bigfoot Medical, etc. The patents are about medical 
alert systems, communication systems for wearable 
devices, Communication methods, and systems for 
medical implants. Table 3 shows the patents 
classificationsbased on their functions. 
Legal Status Analysis 
Although the field of pharmaceuticals has the 
maximum number of patent filings but it has a smaller 
number of patents granted (320) compared to medical 
technology (602). This figure will change overtime as 
the pharmaceutical category has the maximum number 
of patents pending (855). Medical technology is leading 
with lapsed patents (89) and has an insignificant number 
of patents been revoked by the patent offices. This 
indicates that most of the Start-ups rely on their patent 
portfolios and hence the number of lapsed or revoked 
patents is comparatively less with respect to the number 
of patents pending or granted.  
As can be seen from Table 4, ADC Therapeutics 
and Tosense both have the higher number of dead 
patents i.e., they are either revoked or lapsed. This 
shows an incompetent and weak patent portfolio of 
these Start-ups or it can be attributed to the poor 
patent search conducted which has led to patent 
filings of non-novel research findings. Bigfoot 
Medical has an impressive track record with 61 
patents granted and none dead. Verily Life Sciences 
have the maximum number of patents granted (371). 
It is noteworthy that the patents of Editas Medicine, 
Juno Therapeutics, Caribou Biosciences, CRISPR 
Therapeutics, Zymergen, and Poseida Therapeutics all 
cite each other. The patents of Editas Medicine cite 
CRISPR Therapeutics patents nine times and CRISPR 
patents cite Editas patents seven times. Similarly, 
Caribou Biosciences Patents cite Editaspatents three 
times and Editas cites Caribou patents four times. 
Voyager Therapeutics has also cited Translate Bio and 
UniqoreIP patents five times and sixteen times, 
respectively. This shows that the above-mentioned Start-
ups are all working in the same functional area and 
hence so many inter-citations appear. As the Covid-19 
crisis develops, the economic scenario has become 
gloomier and investors might be wary of further 
investment in these Start-up companies. Therefore, this 
citation analysis can also provide a potential opportunity 
for these companies to collaborate or merge in the future 
based on common technological interests.  
Indian Scenario 
Healthcare Sector in India 
The Healthcare Sector in India recorded a total 
funding of US$ 586.93 million in 2019, an increase of 
over 10% from the previous year.11 Therefore, it can 
be said that apart from the stumbling block provided 
by the Covid-19 crisis, the Indian Healthcare Sector 
is growing at a healthy pace. The Medical Device 
Industry alone is expected to be worth US$ 50 billion 
by 2025 in India.12 The Covid-19 crisis also gave 
India an unique opportunity to rectify some of the 
laws regarding medical equipment and drug testing. 
Table 2 — Top assignees in respective categories 





Medical technology Verily Life Sciences 390 
Biotechnology Editas Medicine 
Biotechnology 
53 
Computer Technology Verily Life Sciences 111 
Measurement Verily Life Sciences 106 
Analysis of biological 
materials 
Verily Life Sciences 40 
Optics Verily Life Sciences 150 
Organic fine chemistry Translate Bio 12 
Telecommunications  Verily Life Sciences 48 
Control Verily Life Sciences 37 
Table 3 — Number of patents filed based on their functional area 
Function Number of 
patents filed 
Prevention (Exercise monitoring,  
Fit bit devices) 
221 
Diagnosis (Diagnostic kit,  
Techniques, Image processing) 
605 
Monitor (Disease monitoring,  
Medicine effect monitoring) 
225 
Treatment (Medicines, Injectable devices,  
Gene editing/therapy, etc.) 
2078 
Care (Implants, Telemedicine,  
Database management systems, Prosthetics) 
295 
Others (Communication devices/ protocols for 
implants or emergency SOS systems) 
103 
Table 4 — Legal status analysis of top five assignees 
Assignee Granted Pending Dead 
Verily Life Sciences 371 169 25
ADC Therapeutics 8 22 68
Autolus 3 72 19
Bigfoot Biomedical 61 26 0
Tosense 29 15 43




Earlier, the permission had to be taken from the Drugs 
Controller General of India (DCGI) for testing the 
prototype of a medical device and the permission used 
to be granted within 30 days. However, the crisis 
forced the DCGI to reduce the time to 7 days.13 
 
Start-up Culture in India 
With around 210 incubation centers at present and 
approximately 15 Start-up exchange missions in 
place, India is taking a strong step towards developing 
a Start-up culture.14 Importantly, the entrepreneurs 
that had founded the first generation of Start-ups in 
India have now become angel investors and serial 
entrepreneurs for the next generation of Start-ups and 
entrepreneurs.15 These entrepreneurs can not only 
offer seed funding but also advice upcoming Start-ups 
on policies that may bring success. 
 
Healthcare Start-ups in India 
The ‘Start-up India’ scheme was started in 2016 by 
the government of India to support grassroots 
companies. In India, several telemedicine and online 
pharmacies have mushroomed in Start-up space where 
Practo, 1mg, Cure.fit, Pharmeasy, etc. are emerging as 
leaders. These Start-ups can help India during a crisis 
like Covid-19 when going to the hospitals for regular 
ailments itself brings risk. Online pharmacies have 
helped to reduce unnecessary travel and risk of infection. 
In India, Healthcare Start-ups grew at a CAGR of 50% 
between 2014-19 amounting to 14% of 9200 start-ups 
established between this period. Approximately, 65-67% 
of these healthcare Start-ups are using Artificial 
Intelligence (AI) and 45-46% are making use of Internet 
of Things (IoT) technologies as the backbone of their 
products and solutions.16 An Indian Start-up called 
Fastsense Diagnostics developed a rapid detection kit 
for Covid-19 that can analyze a sample in 15 minutes 
and a confirmatory PCR-based test that can analyze 50 
samples in an hour.17 The company has also filed a 
patent for detecting stages of cancer, the possibility of 
cancer onset, and patient treatment monitoring using a 
single drop of blood.18 
 
Patents Filed in India 
A total of 65 patents were filed with India as the 
priority country. It is noteworthy that despite the 
Start-up culture being relatively new in India, the 
country is among the top 10 patent filers globally. 
More patents are being filed in India in the field of 
medical technology and then in South Korea, 
Australia, and Japan. In India, Sigtuple technology 
has emerged as the largest patent filer with 19 patents 
and most of the patents focus on the analysis of 
biological materials. Forus healthPrivate Limited 
has emerged as the second-largest assignee with  
15 patents. The patents filed are mainly focusing on 
eye care. Sigtuple has filed maximum patents between 
the periods of 2016-18 whereas Vyome Therapeutics 
has been consistently filing patents since 2011. In 
terms of protection countries, Europe followed by the 
USA has emerged as the regions of interest for these 
assignees. Bugworks Research and Vyome 
Therapeuticshave emerged as stand-out patent filers 
with filings in EP, USA, Japan, China, South Korea, 
Mexico, Brazil jurisdictions. The number of diverse 
jurisdictions where patents have been filed shows that 
assignees consider these jurisdictions as potential 
markets where they will be launching their products 
in the future. The strategy can also be considered as a 
mature move where assignees have considered filing 
patents in foreign jurisdictions and thus bearing the 
cost of filing in these territories. The patent filing 
trend obtained from the data showed that the number 
of patents being filed increased gradually since 2016. 
Most of the assignees are registered with the Start-up 
India scheme. The data reflects that Start-ups  
are recognizing the importance of protecting their 
intellectual property. Some of the Start-ups have filed 
only one patent but have chosen multiple jurisdictions 
to protect their invention. 
 
Government Schemes for Start-ups in India 
Some of the benefits provided by the Start-up India 
scheme are i) fast tracking of the patent applications, 
80% Rebate on patent filing fees, ii) relaxed norms 
for participating in government tenders, iii) self-
certification under Labour and Environment Laws, iv) 
insolvency process to be completed in 90 days, and v) 
tax exemption for 3 years. 
 
Funding Source for Start-ups and Few Suggestions for India 
According to a survey by the Reserve Bank of India 
for Start-ups, healthcare has emerged as the  
secondlargest sector in India where Start-ups have 
mushroomed.19 While this is a positive sign for this 
sector, it was also reported that for approximately 43% 
of the Start-ups, the main source of funding remained 
friends and families. It is quite disappointing that despite 
best efforts of the government and monetary provisions 
available by various government agencies for Start-ups, 
the innovators are not aware of them. There might be 
various reasons including lack of information or 
procedural roadblocks which might be discouraging 
entrepreneurs from approaching the government 
agencies for the funds. India can also take inspiration 




from some of its fellow ASEAN countries who have 
taken some innovative steps for developing Start-ups. 
For example, Japan provides Start-up Visa for one year 
to attract foreign investment in the country.20 South 
Korea encourages employees to develop their start-ups 
and promises to re-absorb them in the organization if  
the venture fails.21 China has around 2300 mass 
entrepreneurship spaces and 3000 technology 
incubators.22 Australia provides special fund for 
indigenous tribes to develop start-ups.23 The Global 
Innovation Alliance in Singapore provides an 
entrepreneurial network through which people from 
Singapore can build their network across the globe.24 
 
Conclusion 
The current study dealt with the patent information of 
healthcare Start-ups around the world. Further, it paid 
attention to the Indian scenario. It is interesting to see 
that the maximum number of patents have been filed in 
the field of pharmaceuticals worldwide although there 
are several approval hurdles for products in this area. 
Verily Life Sciences emerged as a giant amongst all the 
assignees with maximum patent filings. It was only 
possible because it had the absolute support of Google. 
The field of biotechnology also showed tremendous 
growth with multiple patent filings across the globe. An 
interesting point is that Canada is a major market for 
most of these companies. Although, Canada is not 
among top ten priority countries, it stands 5th based on 
the publishing data. Several Start-ups like CRISPR 
Therapeutics, Editas Medicine and Caribou Biosciences, 
involved in the patent dispute over CRISPR/ cas9 
technology, are working extensively in this field and 
have filed several patents on this subject. The Indian 
healthcare sector is booming since 2014. Despite, the 
Start-up culture being relatively new in India, the 
country is among the top 10 patent filers globally. More 
patents are being filed in India in the field of medical 
technology than in South Korea, Australia, and Japan. 
Sigtuple Technology has emerged as the largest  
patent filer in India, combining artificial intelligence, 
robotics and data science. Sadly enough, most of the 
entrepreneurs still depend on their family and friends for 
finances. Therefore, some of the practices from ASEAN 
countries have been shared that India can follow to 
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